nucleic acids

envie a um amigo share this

Portuguese researchers discover a new method to detect Helicobacter pylori

Authors and Affiliations:

Sílvia Fontenete1,2,3,4,5,6, Marina Leite2,3, Céu Figueiredo2,3,7, Paul Cos8, Nuno Filipe Azevedo1

1 LEPABE, Laboratory for Process Engineering, Environment, Biotechnology and Energy, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Porto, Portugal.

2 i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.

Investigadores portugueses descobrem novo método de deteção de Helicobacter pylori

Um grupo de investigadores portugueses, em conjunto com distintos grupos de investigadores estrangeiros, da Faculdade de Engenharia da Universidade do Porto, i3S - Instituto de Investigação e Inovação em Saúde, University of Southern Denmark (Dinamarca) e University of Antwerp, (Bélgica) juntaram-se para o desenvolvimento de um novo método que pretende encontrar novas formas de diagnóstico e tratamento da bactéria Helicobacter pylori, a chamada hibridação fluorescente in vivo.

Liquid Biopsies & Cancer

University of Leuven (Leuven, Belgium)

 

28-30 August, 2017

See more informations here: https://kuleuvencongres.be/LKI2017
 

Nanoparticles targeted to brain tumors efficiently deliver nucleic acids to malignant cells rendering them highly susceptible to chemotherapy

A team of Researchers from the Center for Neuroscience and Cell Biology (CNC) developed a nanoparticle capable of delivering therapeutic molecules to malignant brain tumors, which are generally associated with a short life expectancy after diagnosis.

The publication of the study, lead by the CNC researcher Conceição Pedroso de Lima, is the result of four years of work on the development of a new therapy for glioblastoma, a highly malignant and lethal type of brain tumor.